Advanced glycation end products in neurodegeneration: more than early markers of oxidative stress?
Oxidative stress is believed to play a decisive role in the pathogenesis of Parkinson's disease (PD). In addition, Lewy bodies, densely crosslinked intracellular protein deposits formed from cytoskeletal components, accumulate in presymptomatic stages of the disease. Recent findings indicate that "advanced glycation end products" (AGEs) are the major structural crosslinkers that cause the transformation of soluble neurofilament proteins to insoluble Lewy bodies. AGE formation is increased under conditions of oxidative stress, such as early GSH depletion, that are evident in the substantia nigra of PD patients, and is inhibited by radical scavengers and thiol antioxidants. Because AGEs not only are markers of oxidative stress but are also active participants in cell signaling by activation of glial cells to produce superoxide and nitric oxide, they can be considered part of a vicious cycle, which finally leads to neuronal cell death in the substantia nigra in PD.
Münch
G
G
Department of Physiological Chemistry I, Biocenter, University of Würzburg, Germany.
Gerlach
M
M
Sian
J
J
Wong
A
A
Riederer
P
P
D015415:Biomarkers; D005246:Feedback; D017127:Glycation End Products, Advanced; D006801:Humans; D008670:Metals / Q000378:metabolism; D009410:Nerve Degeneration / Q000503:physiopathology*; D010084:Oxidation-Reduction; D018384:Oxidative Stress / Q000502:physiology*; D010300:Parkinson Disease / Q000503:physiopathology*
D015415:Biomarkers; D017127:Glycation End Products, Advanced; D008670:Metals